Rheumatology Academy

Where education meets excellence.
The latest rheumatology CME
& clinical updates you need.

Where education meets excellence.
The latest rheumatology CME & clinical updates you need.

Defining the Challenge in Complex Cases of Psoriatic Arthritis
Defining the Challenge in Complex Cases of Psoriatic Arthritis
Living Rheum
Defining the Challenge in Complex Cases of Psoriatic Arthritis
- Laura Coates, MBChB, MRCP, PhD
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Living Rheum
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
- Laura Coates, MBChB, MRCP, PhD
Progress and Practical Limits with AI in Psoriatic Arthritis
Progress and Practical Limits with AI in Psoriatic Arthritis
AudioAbstracts
Progress and Practical Limits with AI in Psoriatic Arthritis
- Ryan Quigley
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Living Rheum
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
- Ryan Quigley
- Luigi Adamo, MD, PhD
- Andrea Fava, MD
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Living Rheum
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
- Gary S. Firestein, MD
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Living Rheum
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
- Ryan Quigley
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Living Rheum
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Living Rheum
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers